EU's increase in imports of medical dressings in China is positive
The EU is the largest export market for medical dressings in China. In 2010, the EU medical dressing import market reached 1.551 billion U.S. dollars, an increase of 6.8% compared with 1.453 billion U.S. dollars in 2009; compared with the average annual growth rate of imports over 10% before 2009, The recovery has grown but it has not yet reached the level of growth before the financial crisis.
China is the second largest source of imported medical dressings in the European Union after the United States. In 2010, the EU's imports of US medical dressings were 522 million U.S. dollars, a year-on-year decrease of 1.5%; and the related import value to China was 462 million U.S. dollars, an increase of 18.14% compared with 391 million U.S. dollars in 2009, far higher. The overall growth rate of imports of medical dressings in the EU. The proportion of medical dressing products in China in the medical dressing import market in the EU has increased from 21.97% in 2006 to 29.79% in 2010, an increase of nearly 8 percentage points in five years. The market share of US medical dressing products has been declining year by year, from 43.04% in 2006 to 33.66% in 2010. Affected by the financial crisis, the concept of consumption of the EU's citizens has changed and is more sensitive to product prices. With this growth rate, in the next 1 to 2 years, China is expected to surpass the United States and become the largest source of imported medical dressings in the European Union.
EU imports of low-end medical dressings increase steadily
The EU’s import demand for products such as cotton wool, gauze and bandages (Customs Code 300590) showed a steady increase. From 2006 to 2010, the average annual compound growth rate of imports of such products was 9.08%. In 2010, the relevant imports reached 666 million U.S. dollars, accounting for 42.94% of the total imports of medical dressings in the EU during the same period. The competitive advantages of this kind of products in China are obvious. In 2010, the share of the EU import market for cotton wool, gauze, and bandage products reached 52.94%, accounting for half of the country's total. In addition, China's first-aid kits and drug kits account for 85.41% of the EU's import market for similar products, which occupies an absolute advantage.
In the EU import market for aseptic surgical guts, kelp, hemostasis materials and adhesive dressings, the advantages of European and American products are more prominent, and the share of Chinese products is relatively small. However, during the five years from 2006 to 2010, the proportion of our adhesive tape products in the EU's import market for similar products increased by 10.43%. Therefore, in the future, China's products in this category are expected to win more market space in the EU. The market for aseptic surgical guts and kelp products is almost monopolized by the United States and Switzerland. The market share of these two countries totals 85%.